The Scottish Medicines Consortium (SMC) decided in March 2012
that the NHS should not pay for men in Scotland to have
However, abiraterone's manufacturer has resubmitted its
application to the SMC with the offer of a reduced price to the
NHS. The SMC's new decision is expected in August 2012.